JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2005;76:1466-1467; doi:10.1136/jnnp.2005.062737
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Berg, E
Right arrow Articles by Biessels, G J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Berg, E
Right arrow Articles by Biessels, G J
Related Collections
Right arrow Diabetes
Right arrow Dementia

LETTER

Mild impairments in cognition in patients with type 2 diabetes mellitus: the use of the concepts MCI and CIND

E van den Berg, R P C Kessels, E H F de Haan, L J Kappelle, G J Biessels

Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre, Utrecht, Netherlands

Correspondence to:
Correspondence to:
Dr Geert Jan Biessels
Department of Neurology, G03.228, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, Netherlands; G.J.Biessels@med.uu.nl

Keywords: type 2 diabetes mellitus; mild cognitive impairment; dementia

The first 150 words of the full text of this article appear below.

Type 2 diabetes mellitus (DM2) is associated with moderate cognitive impairment in verbal memory, mental flexibility, and information processing speed, while other cognitive functions remain relatively unaffected.1 Moreover, epidemiological studies have shown that DM2 patients have a twofold increased risk of developing either vascular dementia or Alzheimer’s disease.1,2 In the present study we examined whether mild cognitive impairment (MCI) and "cognitive impairment, no dementia" (CIND)—two concepts that are used to describe cognitive impairment in the transitional state between normal aging and early dementia—can be applied to the cognitive impairments encountered in a population based sample of DM2 patients. Recently, these concepts have attracted considerable attention, as individuals who meet the criteria for either MCI or CIND are known to have a substantially increased risk of developing dementia.3,4 MCI is defined as a memory deficit without impairments in other cognitive domains.3 Patients with MCI develop Alzheimer’s disease at an annual incidence . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.